PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $871,733 | +46.7% | 84,063 | +102.6% | 0.00% | +100.0% |
| Q2 2023 | $594,280 | +186.0% | 41,500 | +42.6% | 0.00% | 0.0% |
| Q1 2023 | $207,774 | -30.3% | 29,100 | -17.6% | 0.00% | 0.0% |
| Q2 2022 | $298,000 | -45.5% | 35,304 | -12.2% | 0.00% | -50.0% |
| Q1 2022 | $547,000 | -56.4% | 40,216 | -37.0% | 0.00% | -33.3% |
| Q4 2021 | $1,255,000 | +73.3% | 63,796 | +182.8% | 0.00% | +50.0% |
| Q3 2021 | $724,000 | -46.5% | 22,555 | -43.6% | 0.00% | -33.3% |
| Q2 2021 | $1,353,000 | -34.1% | 39,984 | -26.8% | 0.00% | -40.0% |
| Q1 2021 | $2,053,000 | – | 54,655 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $40,675,000 | 10.18% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $114,625,000 | 8.82% |
| Abingworth LLP | 1,203,135 | $23,606,000 | 5.72% |
| RA Capital Management | 3,115,008 | $61,272,000 | 1.08% |
| Avidity Partners Management LP | 1,896,000 | $37,294,000 | 0.79% |
| StepStone Group LP | 422,085 | $8,302,000 | 0.47% |
| Summit Rock Advisors, LP | 34,100 | $671,000 | 0.40% |
| Parkman Healthcare Partners LLC | 77,481 | $1,524,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 186,210 | $3,624,000 | 0.24% |
| Ikarian Capital, LLC | 74,560 | $1,467,000 | 0.22% |